Current status of 4-aminoquinoline resistance markers 18 years after cessation of chloroquine use for the treatment of uncomplicated falciparum malaria in the littoral coastline region of Cameroon.

MLA

Moyeh, Marcel Nyuylam, et al. “Current Status of 4-Aminoquinoline Resistance Markers 18 Years after Cessation of Chloroquine Use for the Treatment of Uncomplicated Falciparum Malaria in the Littoral Coastline Region of Cameroon.” Pathogens and Global Health, vol. 116, no. 8, Dec. 2022, pp. 509–14. EBSCOhost, https://doi.org/10.1080/20477724.2022.2056674.

APA

Moyeh, M. N., Fankem, S. N., Ali, I. M., Sofeu, D., Sandie, S. M., Njimoh, D. L., Ghogomu, S. M., Kimbi, H. K., & Mbacham, W. F. (2022). Current status of 4-aminoquinoline resistance markers 18 years after cessation of chloroquine use for the treatment of uncomplicated falciparum malaria in the littoral coastline region of Cameroon. Pathogens and Global Health, 116(8), 509–514. https://doi.org/10.1080/20477724.2022.2056674

Chicago

Moyeh, Marcel Nyuylam, Sandra Noukimi Fankem, Innocent Mbulli Ali, Denis Sofeu, Sorelle Mekachie Sandie, Dieudonne Lemuh Njimoh, Stephen Mbigha Ghogomu, Helen Kuokuo Kimbi, and Wilfred Fon Mbacham. 2022. “Current Status of 4-Aminoquinoline Resistance Markers 18 Years after Cessation of Chloroquine Use for the Treatment of Uncomplicated Falciparum Malaria in the Littoral Coastline Region of Cameroon.” Pathogens and Global Health 116 (8): 509–14. doi:10.1080/20477724.2022.2056674.